Levels of innate immune factors in genital fluids: association of alpha defensins and LL-37 with genital infections and increased HIV acquisition.
about
HIV, sexual violence and special populations: adolescence and pregnancyThe Role of Cationic Polypeptides in Modulating HIV-1 Infection of the Cervicovaginal MucosaAntiviral potential of cathelicidinsAntiviral mechanisms of human defensinsDefensins at the Mucosal Surface: Latest Insights into Defensin-Virus InteractionsAntimicrobial peptides in the female reproductive tract: a critical component of the mucosal immune barrier with physiological and clinical implicationsHIV-neutralizing activity of cationic polypeptides in cervicovaginal secretions of women in HIV-serodiscordant relationshipsFactors Driving the HIV Epidemic in Southern Africa.Increased alpha-defensins 1-3 production by dendritic cells in HIV-infected individuals is associated with slower disease progressionAnti-HIV activity in cervical-vaginal secretions from HIV-positive and -negative women correlate with innate antimicrobial levels and IgG antibodiesThe rectal mucosa and condomless receptive anal intercourse in HIV-negative MSM: implications for HIV transmission and preventionHIV-Enhancing and HIV-Inhibiting Properties of Cationic Peptides and Proteins.A randomized trial to assess anti-HIV activity in female genital tract secretions and soluble mucosal immunity following application of 1% tenofovir gel.A comparative proteomic analysis of the soluble immune factor environment of rectal and oral mucosa.Human cathelicidin production by the cervixVitamin D deficiency and altered bone mineral metabolism in HIV-infected individuals.Bridging the gap between preclinical and clinical microbicide trials: blind evaluation of candidate gels in murine models of efficacy and safety.Hormonally active vitamin D3 (1alpha,25-dihydroxycholecalciferol) triggers autophagy in human macrophages that inhibits HIV-1 infection.Innate immunity against HIV: a priority target for HIV prevention researchMucosal immunity in the female genital tract, HIV/AIDSHIV acquisition is associated with increased antimicrobial peptides and reduced HIV neutralizing IgA in the foreskin prepuce of uncircumcised men.Altered biomarkers of mucosal immunity and reduced vaginal Lactobacillus concentrations in sexually active female adolescents.Blunted IL17/IL22 and pro-inflammatory cytokine responses in the genital tract and blood of HIV-exposed, seronegative female sex workers in KenyaInhibition of HIV-1 infection by human α-defensin-5, a natural antimicrobial peptide expressed in the genital and intestinal mucosae.How can we design better vaccines to prevent HIV infection in women?Feasibility and safety of cervical biopsy sampling for mucosal immune studies in female sex workers from Nairobi, KenyaChanges in genital tract immune cell populations after initiation of intrauterine contraception.Effects of tenofovir on cytokines and nucleotidases in HIV-1 target cells and the mucosal tissue environment in the female reproductive tract.Female genital tract secretions and semen impact the development of microbicides for the prevention of HIV and other sexually transmitted infections.Immune responses to HIV in the female reproductive tract, immunologic parallels with the gastrointestinal tract, and research implicationsMucosal human defensins 5 and 6 antagonize the anti-HIV activity of candidate polyanion microbicidesAdolescent girls and young women: key populations for HIV epidemic controlHuman defensins 5 and 6 enhance HIV-1 infectivity through promoting HIV attachment.A cross sectional analysis of the role of the antimicrobial peptide cathelicidin in lung function impairment within the ALIVE cohortInvolvement of neutrophil hyporesponse and the role of Toll-like receptors in human immunodeficiency virus 1 protectionIn vivo evaluation of a mucoadhesive polymeric caplet for intravaginal anti-HIV-1 delivery and development of a molecular mechanistic model for thermochemical characterization.Depot Medroxyprogesterone Acetate Use Is Associated With Elevated Innate Immune Effector Molecules in Cervicovaginal Secretions of HIV-1-Uninfected WomenMolecular Signatures of Immune Activation and Epithelial Barrier Remodeling Are Enhanced during the Luteal Phase of the Menstrual Cycle: Implications for HIV Susceptibility.Factors Important to the Prioritization and Development of Successful Topical Microbicides for HIV-1Innate Antibacterial Activity in Female Genital Tract Secretions Is Associated with Increased Risk of HIV Acquisition.
P2860
Q26825943-730C11F3-355F-4009-A024-41D8D996068DQ27000032-ACB3EFBE-AFF3-4F32-A10A-580C0175C1E2Q27006576-9CEA889A-ED19-4E22-BCE4-B699BC0C8D73Q27023010-65E18C27-029E-4416-8626-07F2A34C2E79Q28078761-C057B2BB-0807-4C4D-9A2E-F5F94551E519Q28087327-96800AFF-C5F9-4BCF-BB81-EE1A41C74DF7Q28731648-75AFD9A1-2B13-4CE4-AE63-64209E398DDBQ30387557-43D4B678-545F-4985-851D-E848D1F2DD93Q33535953-1AA542CF-DC9E-4E58-9197-F19B7188B74FQ33627673-315D8C14-B964-4B91-98F3-E33064273343Q33694217-065428DF-A2B4-4533-9863-CEF6F24779B7Q33753950-2D42F8C4-558D-45A0-9920-D2E56CCF215CQ33808638-3D98C832-8E37-4D23-9CCB-FC70CF7D5EC6Q33825756-2D6BD57F-0456-4297-8D76-A48E3CB8ECFBQ33999248-DEF3458D-8B11-48E0-9D4B-31176E19DEB3Q34016783-C6C0E9B9-926F-42C7-A91F-910378C1B370Q34078011-E1BDF577-4E17-4744-9C55-B815ECA0CEFDQ34174790-C30769B1-9E37-4B85-B3BF-63853E1C946EQ34243462-E7E5B746-72B9-4072-B122-E66AAA4CF2A1Q34275424-AF99435A-BAB2-4A91-BF2B-1D0D9C0F8B76Q34282935-2F42569A-3296-4C11-B613-A01491154628Q34342009-A58B8576-2B3F-41F3-BABE-468A211585FBQ34395906-057753CD-680E-4EBA-AB17-DF1E48DD718EQ34428345-545154C9-9359-4F44-B983-F5EC7E380150Q34449068-2778F9A2-21BF-41CA-A038-C3C85DF3E6C3Q34450955-1DB85AA8-C6A0-467E-9296-EAD88A1000F6Q34506212-471E8C4D-BA53-4DCA-A238-6D33C0828051Q34596532-8710006D-B05A-4D55-B7FB-6DFEA62DAEAEQ34680240-492EAC9F-CE28-44FC-B97D-BAB7D397532BQ34712244-1F5CE3AA-656D-4582-85A1-6A274E5682F0Q34769439-73028B87-30D4-40D1-B94B-099160CB9ECCQ35131236-0DC89EDC-A565-414B-BDEB-FF5EAB1A6C11Q35136126-669A1CD7-94ED-4676-82AB-3D37B86748EAQ35151476-26F2DCA9-2B25-44BF-9B14-252D4F767DDAQ35192491-49CDA7B7-B5EF-4BF4-B0FB-C44E8F356A8BQ35222477-B2BAA086-AB71-402E-AA27-5BEA72C47D77Q35582308-D1DBB9FA-5333-4244-930F-DF874C6D9C9DQ35913894-BB9287FD-536F-4BD1-ADB8-37716D90A1C6Q36111516-A120BCBB-45B9-45BD-BD3B-7A0614B8A3C9Q36294689-C6EFCD08-E5DC-45E0-9229-089D376EB897
P2860
Levels of innate immune factors in genital fluids: association of alpha defensins and LL-37 with genital infections and increased HIV acquisition.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Levels of innate immune factor ...... and increased HIV acquisition.
@en
Levels of innate immune factor ...... and increased HIV acquisition.
@nl
type
label
Levels of innate immune factor ...... and increased HIV acquisition.
@en
Levels of innate immune factor ...... and increased HIV acquisition.
@nl
prefLabel
Levels of innate immune factor ...... and increased HIV acquisition.
@en
Levels of innate immune factor ...... and increased HIV acquisition.
@nl
P50
P1433
P1476
Levels of innate immune factor ...... and increased HIV acquisition.
@en
P2093
Kelly S MacDonald
Pauline Levinson
P304
P356
10.1097/QAD.0B013E328321809C
P407
P50
P577
2009-01-01T00:00:00Z